Related Experiment Video
Updated: May 24, 2026
09:16
Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
Published on: June 18, 2020
Genome-wide association studies in nephrology research
1Renal Division, University Hospital Freiburg, Germany. anna.koettgen@uniklinik-freiburg.de
Summary
Genome-wide association studies are identifying genetic variants linked to kidney diseases. These findings advance understanding of kidney function and disease mechanisms, aiding future prevention and treatment strategies.
Area of Science:
- Nephrology
- Genetics
- Public Health
Background:
- Kidney diseases represent a significant global health challenge with considerable morbidity and mortality.
- Genetic factors contribute to kidney disease, evidenced by heritability studies, monogenic disorders, and familial aggregation of complex kidney diseases.
- Identifying genetic susceptibility variants for complex kidney diseases is challenging due to multiple genetic and environmental risk factors.
Purpose of the Study:
- To provide an overview of genome-wide association studies (GWAS) in nephrology research.
- To summarize recent findings from GWAS related to kidney function and diseases.
- To highlight the potential of GWAS in understanding kidney disease mechanisms and improving patient outcomes.
Main Methods:
- Genome-wide association studies (GWAS) are utilized to identify genetic susceptibility variants.
- Analysis of genomic loci associated with various kidney diseases and kidney function measures.
- Review of published literature on GWAS in the field of nephrology.
Main Results:
- GWAS have successfully identified genomic loci associated with kidney diseases and kidney function.
- Specific gene variants (e.g., UMOD, PRKAG2, CLDN14) are linked to chronic kidney disease and kidney stone disease risks.
- Variants near multiple genes (e.g., SHROOM3, GCKR, SLC34A1) are associated with differences in glomerular filtration rate.
Conclusions:
- GWAS findings represent a crucial initial step in elucidating kidney disease mechanisms.
- Understanding genetic contributions can lead to improved prevention and treatment strategies for kidney diseases.
- Continued application of GWAS in nephrology promises to deepen insights into kidney function and disease pathogenesis.
More Related Videos
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...